Image

    The Relevance of Using 5α-Reductase Inhibitors in the Conservative Management of Benign Prostatic Hyperplasia: A Review

    September 2025 in “ Consilium Medicum ”
    Adel S. Al-Shukri
    Studysummary This study discusses the role of 5α-reductase inhibitors in managing lower urinary tract symptoms caused by benign prostatic hyperplasia and suggests their potential use in other conditions like prostate cancer chemoprevention and androgenetic alopecia treatment, emphasizing appropriate dosing to reduce surgical complications.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on consilium.orscience.ru →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Evaluating 5 Alpha Reductase Inhibitors for the Treatment of Male Androgenic Alopecia Expert Opinion on Pharmacotherapy · 2023
    2. 5-Alpha Reductase Inhibitors Use in Prostatic Disease and Beyond Translational Andrology and Urology · 2023
    3. Pathogenetic Justification of the Use of 5-Alpha Reductase Inhibitors in the Treatment of Benign Prostatic Hyperplasia Experimental and Сlinical Urology · 2022
    4. Sexual Dysfunction in Subjects Treated with Inhibitors of 5α-Reductase for Benign Prostatic Hyperplasia: A Comprehensive Review and Meta-Analysis International Journal of Andrology · 2017